Antidote stock price, funding rounds, valuation and financials

Antidote has raised $17.90 m in total funding. Antidote annual revenue was £1.51 m in FY 2018
View Company

£1.5 M

Antidote Revenue FY, 2018
Antidote Gross profit (FY, 2018)447.6 K
Antidote Gross profit margin (FY, 2018), %29.6%
Antidote Net income (FY, 2018)-5.3 M
Antidote EBIT (FY, 2018)-5.5 M
Antidote Cash, 31-Dec-20181 M

Antidote Revenue

Antidote revenue was £1.51 m in FY, 2018

Embed Graph

Antidote Funding

Summary Metrics

Founding Date

2009

Antidote total Funding

$17.9 m

Antidote latest funding size

$13.50 m

Time since last funding

5 years ago

Antidote investors

Amadeus Capital Partners, Smedvig Capital, Octopus Ventures
Antidote's latest funding round in February 2015 was reported to be $13.5 m. In total, Antidote has raised $17.9 m

Antidote Capital Raised

Embed Graph

Antidote Income Statement

Annual

GBPFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

2.2m2.4m2.2m1.5m

Revenue growth, %

8%(11%)

Cost of goods sold

912.3k1.1m892.3k1.1m

Gross profit

1.3m1.3m1.3m447.6k

Gross profit Margin, %

59%53%59%30%

Operating expense total

3.8m4.9m6.2m

Depreciation and amortization

39.1k

EBITDA

(2.5m)(3.6m)(4.9m)

EBITDA margin, %

(110%)(151%)(229%)

EBIT

(2.5m)(3.7m)(5.0m)(5.5m)

EBIT margin, %

(110%)(152%)(231%)(366%)

Interest expense

Interest income

Pre tax profit

(2.5m)(3.7m)(5.0m)(5.5m)

Income tax expense

(218.5k)(375.3k)(396.4k)(276.4k)

Net Income

(2.2m)(3.3m)(4.6m)(5.3m)

Antidote Balance Sheet

Annual

GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

284.3k1.9m147.5k1.3m2.3m6.1m1.0m

Accounts Receivable

73.1k211.4k504.2k647.1k967.5k509.6k268.6k

Inventories

Current Assets

357.4k2.1m651.8k2.2m3.7m7.2m1.8m

PP&E

1.5k6.7k14.9k85.5k77.0k66.4k52.2k

Total Assets

388.1k2.1m666.7k2.4m3.9m7.4m2.0m

Accounts Payable

23.9k61.6k1.0m226.3k77.5k197.3k57.9k

Short-term debt

Current Liabilities

23.9k61.6k1.0m442.1k638.8k641.4k479.3k

Long-term debt

Non-Current Liabilities

54.0k132.5k90.7k48.9k

Total Debt

Total Liabilities

23.9k61.6k1.0m496.0k771.4k732.2k528.2k

Common Stock

43.0k45.1k44.3k45.0k45.9k48.7k65.8k

Retained Earnings

(730.6k)(3.2m)(5.4m)(8.7m)(13.3m)(18.6m)

Total Equity

364.2k2.1m(363.4k)1.9m3.1m6.7m1.5m

Financial Leverage

1.1 x1 x-1.8 x1.3 x1.2 x1.1 x1.4 x

Antidote Cash Flow

Annual

GBPFY, 2015FY, 2016FY, 2017

Net Income

(2.2m)(3.3m)(4.6m)

Antidote Ratios

GBPY, 2018

Revenue/Employee

23.0k

Financial Leverage

1.4 x

Antidote Employee Rating

4.55 votes
Culture & Values
4.4
Work/Life Balance
4.8
Senior Management
4.7
Salary & Benefits
3.8
Career Opportunities
4.3
Source
View Antidote profile

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Learn more